CARDIOL THERAPEUTICS INC-A (CRDL) Institutional Ownership Changes & 13F Activity
CARDIOL THERAPEUTICS INC-A (CRDL). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Mmcap International Inc. Spc, Ikarian Capital, Llc, Citadel Advisors Llc, Boothbay Fund Management, Llc, and Renaissance Technologies LLC.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Pvg Asset Management Corp | Buy | +107,165 | — | 107,165 | $112.52K | Q1 2026 | Jun 16, 2026 |
| Mmcap International Inc. Spc | Buy | +15,143,367 | +7247.4% | 15,352,317 | $20.73M | Q1 2026 | May 15, 2026 |
| Ikarian Capital, Llc | Buy | +2,725,000 | — | 2,725,000 | $3.68M | Q1 2026 | May 15, 2026 |
| Citadel Advisors Llc | Buy | +819,904 | — | 819,904 | $1.11M | Q1 2026 | May 15, 2026 |
| Boothbay Fund Management, Llc | Buy | +794,881 | — | 794,881 | $1.07M | Q1 2026 | May 15, 2026 |
| Susquehanna International Group, Llp | Sell | -133,330 | -65.4% | 70,396 | $95.03K | Q1 2026 | May 15, 2026 |
| Two Sigma Investments, Lp | Buy | +127,276 | +31.3% | 534,211 | $721.18K | Q1 2026 | May 15, 2026 |
| Morgan Stanley | Sell | -94,042 | -27.3% | 250,421 | $338.07K | Q1 2026 | May 15, 2026 |
| Quadrature Capital Ltd | Buy | +47,887 | — | 47,887 | $64.65K | Q1 2026 | May 15, 2026 |
| Scientech Research Llc | Buy | +15,178 | — | 15,178 | $20.49K | Q1 2026 | May 15, 2026 |
| Advisory Services Network, Llc | Buy | +10,000 | — | 10,000 | $13.50K | Q1 2026 | May 15, 2026 |
| Royal Bank Of Canada | Buy | +8,306 | +62.3% | 21,648 | $29.00K | Q1 2026 | May 15, 2026 |
| Goldman Sachs Group Inc | Buy | +3,900 | +1.2% | 332,400 | $448.74K | Q1 2026 | May 15, 2026 |
| National Bank Of Canada | Buy | +622 | +36.6% | 2,323 | $3.14K | Q1 2026 | May 15, 2026 |
| Barclays Plc | Buy | +200 | — | 200 | $270.00 | Q1 2026 | May 15, 2026 |
| Osaic Holdings, Inc. | Sell | -187 | -27.2% | 500 | $675.00 | Q1 2026 | May 15, 2026 |
| Renaissance Technologies LLC | Buy | +229,806 | — | 229,806 | $310.24K | Q1 2026 | May 14, 2026 |
| Virtu Financial Llc | Buy | +23,917 | — | 23,917 | $32.00K | Q1 2026 | May 14, 2026 |
| Kovack Advisors, Inc. | Buy | +30,000 | — | 30,000 | $42.00K | Q1 2026 | May 13, 2026 |
| Jane Street Group, Llc | Buy | +87,129 | +218.8% | 126,957 | $172.43K | Q1 2026 | May 12, 2026 |
| Bnp Paribas Financial Markets | Buy | +10,000 | — | 10,000 | $13.50K | Q1 2026 | May 12, 2026 |
| Td Waterhouse Canada Inc. | Sell | -300 | -4.2% | 6,900 | $9.49K | Q1 2026 | May 12, 2026 |
| Integrity Alliance, Llc. | Buy | +30,000 | +6.9% | 465,025 | $629.83K | Q1 2026 | May 11, 2026 |
| Baader Bank Aktiengesellschaft | Buy | +15,932 | — | 15,932 | $10.17K | Q1 2026 | May 08, 2026 |
| Ubs Group Ag | Sell | -7,940 | -48.0% | 8,609 | $11.62K | Q1 2026 | May 05, 2026 |
| Commonwealth Equity Services, Llc | Buy | +370 | +3.4% | 11,100 | $14.98K | Q1 2026 | Apr 27, 2026 |
| Boomfish Wealth Group, Llc | Buy | +14,423 | — | 14,423 | $19.47K | Q1 2026 | Apr 22, 2026 |
| Eaton Financial Holdings Company, Llc | Buy | +14,000 | — | 14,000 | $18.90K | Q1 2026 | Apr 15, 2026 |
| Boyer Financial Services, Inc. | Sell | -10,000 | -30.2% | 23,100 | $31.18K | Q1 2026 | Apr 10, 2026 |
| Newedge Advisors, Llc | Sell | -5,000 | -100.0% | 0 | $0.00 | Q1 2026 | Feb 18, 2026 |
Frequently asked questions about CRDL activity
Which institutional owners are buying CRDL?
Institutional owners buying CRDL include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CRDL activity?
"Buy" means an investor increased their reported position in CRDL compared to the prior reporting period. This reflects growing exposure to CARDIOL THERAPEUTICS INC-A (CRDL) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CRDL increasing?
Institutional interest in CRDL can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related CRDL Institutional Insights
- CRDL Overview
- CRDL 13F Institutional Holders
- CRDL Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- CRDL Insider Trading & SEC Form 4 Activity
- CRDL Articles
- Top Institutional Investor Stock Rankings